BATON ROUGE- Critics across the country ask why Dsuvia's drugs are needed. Opioid and new pitcher have recently given the FDA approval stamp, but many disagree and think it is a terrible mistake.
"We are at the heart of the worst epidemic, the opioid epidemic in this country, which will probably kill and injure more people than any other epidemic than the country, or the world has seen , "says Coroner Beau Clark.
Eastern Baton Rouge Parish Coroner, Dr. Clark Clark has seen the fatal effects of Opioid use with at least 72 overdose deaths in the parish alone this year.
"This seems to be a very great disregard for human life. We talk about substance, Opioids that kill people, why we need more when we have a problem with what we have , "said Clark.
According to the FDA, there is strict guidelines for the drug that can abolish in your mouth. Only in hospitals, surgical centers, and emergency rooms can be used. Dsuvia should not be used for more than 72 hours, and is not available in retail pharmacies.
They say that this is a drug that will only be administered in a healthcare facility for a very short time in a very controlled environment. That's great if that's the case. However, later in the statement, they say that this has also been developed with the Department of Defense, so it also contradicts itself.
In a statement of the FDA commission, Dr. Scott Gottlieb, "This Opioid formula, together with Dsuvia's unique supply device, is a priority product for the Pentagon because it fills a specific and essential need but is not met when treating our nation's troops on the battlefield, but not Dr. Clark is buying it.
"A soldier out protects our country, and if they are injured in the battlefield, we have to have mechanisms to control their pain, especially if they have a long transport time where they get accused and definitive care but I believe that those things already exist, "Clark said.
Serious risks of using the Dsuvia include depression, coma, and death even without mentioning the extremely addictive quality.
"Having stronger and stronger Opioids is an incorrect address, and surely sends the wrong message." In Dr Gottlieb's statement regarding Dsuvia, he added: "I will not highlight what I think is the real source source of dissatisfaction among critics of this approval as to whether America needs another powerful opioid, and ultimately a huge crisis of dependence. "
Gottlieb says that the question will be addressed openly and directly. Dsuvia is about to bring 1.1 billion dollars in an annual sales, but to Clark, he is more concerned about the lives that could be lost in the future.
"We're on track for another one year of increase in the Opioid number compared to even last year, and I do not see an end to sight, and when we do something like this , and we're creating another even more powerful Opioid category that I believe is causing more and more problems, "said Clark.
For more information about Dsuvia, click here.